TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
| Image |  |
|---|---|
| Description | scientific article published on 03 April 2009 |
| Author/s |
author: Barney S. Graham |
| Publication date | April 3, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |